Bickerstaff's brainstem encephalitis associated with anti-GM1 and anti-GD1a antibodies

BMJ Case Rep. 2020 Sep 18;13(9):e236545. doi: 10.1136/bcr-2020-236545.

Abstract

Bickerstaff's brainstem encephalitis (BBE) is a Guillain-Barré syndrome (GBS) spectrum disorder associated with predominantly central nervous system predilection. Patients exhibit a variable constellation of depressed consciousness, bilateral external ophthalmoplegia, ataxia and long tract signs. Although the pathophysiology is not fully understood, it has been associated with anti-GQ1b antibodies in two-thirds of patients. We present a patient with clinical features consistent with BBE and positive anti-GM1 and anti-GD1a antibodies. A diagnostic approach to the acutely unwell patient with brainstem encephalitis is explored in this clinical context with a literature review of the aforementioned ganglioside antibody significance. Intravenous immunoglobulin therapy is highlighted in BBE using up-to-date evidence-based extrapolation from GBS.

Keywords: brain stem / cerebellum; cranial nerves; neuro ITU; neurology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Ataxia / blood
  • Ataxia / immunology*
  • Autoantibodies / blood*
  • Autoantibodies / immunology
  • Brain Stem / immunology*
  • Diagnosis, Differential
  • Electroencephalography
  • Encephalitis / blood
  • Encephalitis / complications
  • Encephalitis / diagnosis*
  • Encephalitis / immunology
  • G(M1) Ganglioside / immunology
  • Gangliosides / immunology
  • Glasgow Coma Scale
  • Humans
  • Male
  • Ophthalmoplegia / blood
  • Ophthalmoplegia / immunology*

Substances

  • Autoantibodies
  • Gangliosides
  • ganglioside, GD1a
  • G(M1) Ganglioside